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1. Introduction 
Rapid reperfusion improves mortality in patients with acute ST- elevation myocardial 
infarction (STEMI). Moreover, achieving reperfusion by primary percutaneous coronary 
intervention (PCI) instead of fibrinolytic therapy is preferred because patients have less 
strokes, less nonfatal reinfarctions, and a lower mortality rate (Keeley et al., 2003). However, 
because achieving perfusion with primary PCI sometimes involves transporting patients from 
the location where the diagnosis was made to a catheterization laboratory, and once in the 
catheterization laboratory numerous technical and clinical problems must be successfully 
managed, there is a significant time delay. In some studies, this time delay has been associated 
with an increased mortality (Boersma, 2006; Nallamothu and Bates, 2003). Furthermore, the 
advantages of primary PCI over thrombolytic therapy may be negated if the time to 
reperfusion with primary PCI exceeds that of fibrinolytic therapy by one hour or more 
(Nallamothu and Bates, 2003). In absolute terms, when patients are selected for the primary 
PCI strategy, every minute of delay to reperfusion affects the one-year mortality. In one study, 
the one-year mortality was increased by 7.5% for every 30 minute delay (De Luca et al., 2004). 
With these factors in mind, the American Heart Association/American College of Cardiology 
(AHA/ACC) guidelines for STEMI recommend that the interval between arrival at the 
hospital and treatment of the coronary lesion with a balloon inflation (door-to-balloon time) 
should be 90 minutes or less (Antman et al., 2004). Conjointly, in the United States the Centers 
for Medicare and Medicaid Services (CMS) and the Joint Commission on Accreditation of 
Healthcare Organizations have included this goal as one of their core quality measures. 
Subsequently, institutions responsible for quality improvement in patients with STEMI were 
created to focus on factors that increase door-to-balloon times (Singh and Harrington, 2007). 
Most of the barriers that affect the time interval from patient presentation to the arrival of the 
patient in the catheterization laboratory have been identified and significant improvements 
have been made (Bradley et al., 2006; Kraft et al., 2007). Less attention, however, has been 
directed toward reducing delays after the patient enters the catheterization lab. This chapter 
will focus on methods clinicians have used to decrease the time between establishment of 
arterial access and successful coronary reperfusion in patients with STEMI. 
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2. Electrocardiogram (EKG) - directed PCI in patients with STEMI 
In patients with STEMI, an EKG is an essential roadmap if the culprit vessel is visualized 
and then treated first before performing any other diagnostics. In a retrospective study, 
Lachance and colleagues used the EKG to determine the culprit vessel in patients 
undergoing primary PCI for STEMI. In one group, they imaged and then immediately 
percutaneously treated the culprit vessel before performing a complete coronary and left 
ventricular evaluation. In another group, they performed complete coronary catheterization 
and then PCI. Acute myocardial infarction by EKG was defined as chest pain or the 
equivalent symptoms at rest greater than 30 minutes, with either ST-segment elevation in 
greater than two contiguous leads (greater than 2 mm in the precordial lead, greater than 1 
mm in the limb lead), ST-segment depression greater than 1 mm in the precordial leads, or 
new or presumed new left bundle branch block (LBBB). In the group where the culprit 
vessel was treated first, the actual culprit vessel was the presumed culprit vessel by EKG 
most of the time. Specifically, the EKG correctly diagnosed the culprit vessel in 83 of these 
87 patients (95%). In this study, however, patients who had previous coronary artery bypass 
surgery (CABG) and those with thrombolysis in myocardial infarction (TIMI) 2 to 3 flow in 
the culprit vessel were excluded from the analysis (LaChance et al., 2008). Similarly, in the 
retrospective study by Applegate and colleagues, an EKG in the emergency room 
determined the presumed culprit vessel in the culprit PCI group. The presumed culprit 
vessel was the actual culprit vessel in 49 of the 50 patients. In one patient, a right coronary 
guide was chosen but the culprit vessel was a distal dominant left circumflex coronary 
artery. Left main or severe three-vessel coronary artery disease was found in only 2% of the 
patients in the culprit vessel group (Applegate et al., 2008). 
3. Arterial access 
In the catheterization laboratory, several critical but time-consuming steps are performed to 
help make important decisions not only about revascularization, but also about overall 
patient management. The first of these involves the location of arterial access. The most 
common access routes include the femoral, the brachial and the radial artery. In patients 
undergoing PCI for STEMI, various potent antiplatelet and anticoagulant therapies are 
required. As a result, bleeding at vascular access sites, particularly the femoral artery, is an 
important and common cause of morbidity and mortality (Hetherington et al., 2009). 
Comparatively, the radial artery in this setting, has been associated with minimal or no 
bleeding complications. Despite this, the femoral artery has been the access site of choice in 
the United States. Reasons for this include the learning curve associated with performing 
cardiac catheterizations via the radial artery, and difficulty achieving radial access in certain 
patients despite having considerable experience. With good reason, operators have been 
concerned that these difficulties may increase door to balloon times. Several studies have 
evaluated this concern. Cantor and colleagues in a small multicenter study randomized 50 
patients with acute myocardial infarction requiring either primary or rescue PCI to radial or 
femoral access. Operators in this study had significant experience with the transradial 
approach. They reported their times from local anesthesia to first balloon inflation at 32 
(25th percentile 26, 75th percentile 38) minutes for radial access and 26 minutes (25th 
percentile 22, 75th percentile 33) for femoral access (P=0.04). Reperfusion success rates were 
high and comparable with either approach (Cantor et al., 2005). In another randomized 
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study, however, not only were the success rates for perfusion high and similar in both 
groups, procedure time was less in the transradial group compared to the transfemoral 
group (44 minutes ± 18, versus 51 minutes ± 21) (Saito et al., 2003). Non-randomized studies 
investigating these approaches in patients with STEMI, where the location of access is left to 
the discretion of the interventionalists, have reported lower or similar access to reperfusion 
times with the transradial approach compared to the femoral approach (Hetherington et al., 
2009; Larrazet et al., 2003; Pancholy et al., 2010; Weaver et al., 2010). 
These data suggest that the transradial approach may be preferable to the transfemoral 
approach in patients being treated for STEMI. Furthermore, in patients where femoral access 
is extremely difficult to obtain, the radial artery provides an attractive alternative. As 
attractive as the radial approach may seem, there are important points to highlight. There is 
a significant learning curve associated with radial access. In studies where low failure rates 
via the radial artery approach were reported, most of the operators already performed more 
than 1000 radial cardiac catheterizations (Agostoni et al., 2004). In addition, in the non-
randomized studies where the choice of access was left to the discretion of the operator, 
patients with coronary artery bypass grafts of unknown anatomy were more likely to have 
been performed via the femoral approach. Also, access site crossover is higher when the 
radial artery access is used. That is, if the initial approach by the radial artery is unsuccessful 
the procedure has to be performed via the femoral approach. Consistently, a crossover rate 
of 7% has been observed in most of the studies investigating these approaches. Lastly, the 
radial approach is often limited by the size of the sheath (not more than 6 French). Placing a 
7 or 8 French sheath, which can help provide more support during the procedure, is 
associated with a higher risk of radial arterial spasm, and thus a lower procedural success 
rate (Agostoni et al., 2004; Weaver et al., 2010). Despite these obstacles, it seems that a 
catheterization laboratory team dedicated to the radial approach can achieve comparative 
door to balloon times with the benefit of decreased morbidity and mortality related to major 
bleeding in patients with STEMI. 
There are little data comparing brachial arteriotomy with other locations of vascular access 
in patients undergoing PCI for STEMI. In general the brachial approach, like the radial 
artery approach, is used in patients with severe peripheral vascular disease, or where there 
is an increased risk of bleeding (due to anticoagulation or recent thrombolytic therapy). 
Another advantage of this approach, as opposed to the radial artery is the ability to use 7 
French or greater catheter sizes. Complications with the brachial artery, however, include 
median nerve injury from compression by a hematoma, which can potentially lead to 
irreversible nerve damage. Thus in our laboratory, the radial artery is preferred over the 
brachial artery for vascular access in selected patients with STEMI. 
4. Culprit vessel PCI versus traditional catheterization and PCI for STEMI: 
Door to balloon times 
Comprehensive coronary angiography can identify STEMI patients who may benefit from 
an urgent surgical approach. Left ventriculography can quantify left ventricular function, 
left ventricular end-diastolic pressure; exclude mechanical complications including mitral 
regurgitation, pseudoaneurysms or a ventricular septal defect. This strategy also allows 
identification of left main and severe three-vessel coronary artery disease upfront. 
Performing EKG-directed directed PCI, however, after achieving arterial access and prior to 
routine coronary angiography with or without left ventriculography has been shown to 
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decrease door to balloon times in two small studies (Applegate et al., 2008; LaChance et al., 
2008). 
In the first study, Applegate and colleagues reviewed 135 consecutive patients who 
underwent primary PCI for STEMI from July 2005 to June 2007. During the study period, 
five patients who underwent primary PCI for STEMI were excluded because of incomplete 
door-to-balloon time data. No other patients were excluded from this analysis. Eighty-five 
STEMI patients who underwent complete coronary angiography followed by culprit lesion 
PCI served as the control group. The study group consisted of 50 STEMI patients who first 
underwent culprit PCI followed by complete coronary angiography. The strategy for 
achieving reperfusion was at the discretion of the interventionalist performing the 
procedure. During the study period, six interventionalists performed primary PCI 
for STEMI. Concern about performing PCI prior to the availability of information 
from complete coronary angiography, prior coronary artery bypass graft surgery (CABG) 
and indicators of cardiogenic shock on admission were factors in determining the decision 
to perform culprit versus traditional PCI by some interventionalists (Applegate et al., 
2008). 
In the traditional PCI group, vascular access was obtained using the femoral approach. 
Complete coronary angiography was then performed followed by left ventriculography at 
the discretion of the interventional cardiologist. Identification of the culprit lesion was based 
on composite assessment of the ECG, coronary angiogram, and left ventriculogram if 
available. The choice of equipment for PCI was left to the discretion of the attending 
physician performing the procedure, including guide catheter shape and size (6 or 7 
French). In the culprit PCI group, the location of the presumed infarct lesion was based only 
on the initial ECG obtained in the emergency department. In these patients, after vascular 
access was obtained, a guide catheter was advanced and PCI was performed immediately, 
prior to complete coronary angiography or left ventriculography. Following PCI, coronary 
angiography was completed, with left ventriculography performed at the discretion of the 
interventionalist. 
The baseline clinical characteristics of the culprit and traditional groups were similar 
although patients were younger in the culprit vessel group (56 ± 10 years versus 60 ± 13 
years) versus the traditional group, p=0.029 (Table 1). The target vessel was more often the 
right coronary artery (70% versus 49%, p=0.020) in the culprit versus the traditional group. 
Procedural characteristics were similar, although fewer drug-eluting stents were used in the 
culprit vessel group (60%) compared to the traditional group (76%, p=0.043). Door-to-
balloon times were shorter in the culprit vessel group (66 ± 20 minutes) than in the 
traditional group (79 ± 28 minutes, p=0.003). This was achieved primarily because of a 
shorter vascular access-to-balloon time in the culprit group (11 ± 8 minutes) than in the 
traditional group (18 ± 8 minutes, p<0.001). Door-to-vascular access times were similar for 
the two groups:  55 ± 18 minutes in the culprit group, versus 61 ± 24 minutes in the 
traditional group; p=0.10. Ninety- two percent of the culprit group patients achieved a door-
to-balloon time <90 minutes, compared to 76% in the traditional group; p=0.023. In 62% of 
the traditional PCI group, left ventriculography was performed after the PCI. Door-to-
balloon times were still significantly lower in the culprit vessel PCI group (17 ± 9 minutes) 
than in this subgroup of traditional PCI patients (22 ± 7 minutes; p<0.001). 
Thirty-day outcomes are shown in Table 2. Planned revascularization procedures after the 
index PCI were performed in two culprit vessel patients, and in 1 traditional patient; p=0.28.  
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 Characteristic 
Traditional PCI 
{n = 85} 
Culprit Vessel PCI 
{n = 50} 
p Value 
Male gender, n {%} 70 {82} 39 {78} 0.536 
Age, years 60 ± 13 56 ± 10 0.029 
Heart failure class III or IV,  
n {%} 
5 {6} 1 {2} 0.412 
Current smoker, n {%} 48 {56} 27 {54} 0.780 
Diabetes mellitus, n {%} 18 {21} 10 {20} 0.871 
Hypertension, n {%} 56 {66} 31 {62} 0.649 
Hypercholesterolemia, n {%} 47 {55} 35 {70} 0.091 
Vascular disease, n {%} 9 {11} 3 {6} 0.366 
History of renal failure, n {%} 3 {4} 1 {2} 0.613 
Previous PCI, n {%} 20 {24} 17 {34} 0.188 
Previous CABG, n {%} 5 {6} 3 {6} 0.978 
Left ventricular ejection 
fraction, {%} 
45 ± 10 45 ± 9 0.921 
Vessels disease, n 1.7 ± 0.8 1.6 ± 0.8 0.512 
Severe 3-vessel or LMCA 
disease, n {%} 
7 {8} 1{2} 0.138 
Cardiogenic shock, n {%} 6 {7} 2 {4} 0.467 
IABP inserted, n {%} 6 {7} 2 {4} 0.467 
CABG = coronary artery bypass surgery, IABP = intra-aortic balloon pump; LMCA = left 
main coronary artery disease; PCI = percutaneous coronary intervention 
Table 1. Baseline clinical characteristics by percutaneous coronary intervention method. 
 
 
Outcome 
Traditional PCI 
{n = 85} 
Culprit Vessel PCI 
{n = 50} 
p Value 
Planned revascularization, n {%} 1 {1.2} 2 {4.0} 0.283 
Death, n {%} 1 {1.4} 1 {2.0} 0.702 
Nonfatal MI, n {%} 0 {0} 0 {0} --- 
Nonfatal MI or death, n {%} 1 {1.4} 1 {2.0} 0.702 
Stent thrombosis, n {%} 0 {0} 0 {0} --- 
Target vessel revascularization, n {%} 0 {0} 0 {0} --- 
Any major adverse cardiac event,  
n {%} 
1 {1.4} 1 {2.0} 0.702 
MI = myocardial infarction; PCI = percutaneous coronary intervention 
Table 2. Major adverse cardiac events out to 1 month by percutaneous coronary intervention 
method. 
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There were no stent thromboses or recurrent nonfatal MIs in either group after 30 days of 
follow up. One patient in each group died during the initial hospitalization (p=0.70), and 
none thereafter. 
In this study, door-to-balloon times were reduced when culprit vessel PCI was performed 
before complete coronary angiography and left ventriculography. The benefit was due to a 
decrease in the vascular access-to-balloon time of 7 minutes. Importantly, this benefit was 
achieved when efforts to reduce door-to-balloon times under 90 minutes had already been 
implemented, with an average door-to- balloon time of 79 minutes in the traditional PCI 
group. Significant left main or three-vessel coronary artery disease, cardiogenic shock or 
mechanical complications of MI were infrequently observed and were similar in each group. 
Specifically, severe three vessel or left main coronary artery disease was seen in 8% of the 
traditional PCI patients and in 2% of the culprit vessel PCI patients (p=0.138). Cardiogenic 
shock was seen in 7% of the traditional PCI patients and 4% of the culprit vessel PCI patients 
(p=0.467). In this study, no mechanical complications were diagnosed by ventriculography. 
In-hospital and thirty-day outcomes were similar between the two groups. 
A similar study performed by Lachance and colleagues compared the door-to-balloon times 
in a group of STEMI patients assigned to EKG-guided culprit vessel PCI (group 1) and 
another group assigned to traditional PCI (group 2) retrospectively (Lachance et al., 2008). 
Two hundred and seventy-nine patients were included in the analysis. These consecutive 
patients underwent primary PCI at Laval Hospital, Quebec, Canada between May 2006 and 
August 2007. Eighty-seven patients were in the first group and 192 patients were in the 
second group. The type of procedural strategy was left to the discretion of the 
interventionalists. The baseline characteristics, including clinical, procedural and lesion 
type, were similar between the two groups. Median catheterization lab door-to-balloon 
times were 21 minutes in group 1 and 25.5 minutes in group 2 (P<0.0001). The median door-
to-balloon time was 80 minutes for patients in group 1 and 90 minutes for patients in group 
2 (p=0.01). Compared to group 2, more patients in group 1 received reperfusion in less than 
90 minutes (63% versus 49%; p=0.04). Three STEMI patients in this cohort were referred for 
coronary artery bypass surgery. One patient, who had an anterior MI, was in group 2. This 
patient had a diagnostic right coronary angiogram performed, which revealed moderate 
stenosis. The left coronary angiogram then revealed severe stenosis of the left main artery 
and occlusion of the left anterior descending artery. The patient was then referred for urgent 
coronary artery bypass grafting. The second patient was in group 1 and presented with ST- 
elevations in the inferior leads. An angiogram of the right coronary artery was performed 
with a guiding catheter and no significant stenosis was seen. Coronary angiography of the 
left coronary artery revealed a severe stenosis of the left main. This patient underwent 
coronary artery bypass grafting two days after coronary angiography. The third patient 
presented in cardiogenic shock and an echocardiogram was performed before coronary 
angiography. This revealed a ventricular septal defect and mitral regurgitation. The patient 
was then referred for urgent cardiac surgery. In the study by Lachance, no mechanical 
complications were diagnosed by ventriculography. After one year of clinical follow-up, 
there was no difference between groups in rates of death, reinfarctions, or need for repeat 
PCI. Because these are small retrospective studies, however, further studies are needed not 
only to determine if the culprit vessel PCI strategy for STEMI consistently lowers door-to-
balloon times, but also, if it improves clinical outcomes. 
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Observational studies such as ours and that of Lachance may be subject to selection bias. 
Randomized clinical trials would provide the fairest evaluation of culprit vessel versus 
traditional PCI for STEMI. The decision to perform culprit versus traditional PCI could have 
been influenced by important patient and procedural factors that relate to the outcomes of 
the study, such as age, prior PCI or CABG, and infarct location. While we cannot exclude 
this possibility, culprit and traditional patient groups had similar baseline clinical and lesion 
characteristics in both these studies. Moreover, among the interventionalists performing 
culprit PCI for STEMI, no patient or procedural factors seemed to influence strongly the 
decision to perform culprit PCI. While there remains a concern that discovery of important 
clinical information after first performing culprit PCI would surface, in both these studies, 
this was observed infrequently. These concerns need to be evaluated in larger groups of 
patients before accepting this strategy as standard clinical practice. Also, the study groups 
were small and studies in larger groups of patients will need to be performed to determine 
if the strategy evaluated in this study is both feasible and beneficial in broader clinical 
practice. Hopefully, longer-term follow-up of cohorts will provide valuable information 
concerning the relative benefit of culprit vessel versus traditional PCI for STEMI. 
5. Culprit vessel PCI versus traditional catheterization and PCI for STEMI: Is 
there a potential for harm? 
Efforts to reduce door-to-balloon times have focused on reducing the time spent prior to 
getting the patient in the cardiac catheterization laboratory (Bradley et al., 2006; Eagle et al., 
2002; Kraft et al., 2007; Kurz et al., 2007). However, there have been few efforts aimed at 
further reducing door-to-balloon times within the cardiac catheterization laboratory itself 
(Bradley et al., 2006; Burzotta et al., 2008). Traditionally, patients undergoing urgent 
percutaneous revascularization initially undergo complete coronary angiography, with or 
without left ventriculography. This strategy allows identification of life-threatening disease 
that may require urgent surgery. In the United States, this traditional approach to the 
patient requiring emergency revascularization, including STEMI patients has been utilized 
in most laboratories. However, several factors have evolved in the contemporary care of 
patients with coronary artery disease that are relevant to this approach. First, the actual 
number of cases undergoing emergency revascularization procedures requiring CABG has 
dramatically fallen in the past decade (Seshadri et al., 2002; Yang et al., 2005). For example, 
Yang and colleagues reported a significant decrease in the incidence of emergency CABG 
from 2.9% to 0.7% to 0.3% across three groups (the “pre-stent” era, 1979 to 1994; the “initial 
stent era,” 1995 to 1999; and the “current stent era,” 2000 to 2003 in 23,087 patients 
undergoing PCI at the Mayo Clinic from 1979 to 2003. This trend was observed despite 
higher risk features in the more recent patient cohorts. Second, mobilization of the operating 
room, even under the best of circumstances, generally exceeds a satisfactory time to achieve 
reperfusion in STEMI patients. Finally, there has been a growing acceptance of hybrid 
revascularization procedures utilizing both PCI and CABG, either at the same time, or as 
part of a planned revascularization strategy (Friedrich and Bonatti, 2007). Thus, the 
identification of left main or three-vessel coronary disease itself is not a contraindication to 
performing PCI of a culprit vessel in a STEMI patient with a staged CABG as deemed 
necessary. 
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6. Traditional catheterization and PCI versus culprit vessel PCI versus a 
hybrid approach for STEMI 
The benefits of performing primary PCI for STEMI, and the need for PCI centers to achieve 
door-to-balloon times less than 90 minutes, has led to the strategy of performing culprit 
vessel PCI, even in the setting of left main or significant multivessel disease. Once the 
decision to perform culprit vessel PCI has been made, the next choice is the stent type, that 
is, bare metal stent versus drug-eluting stent. The merits of bare metal and drug-eluting 
stent  implantation in STEMI have been the subject of several studies and meta-analyses (De 
et al., 2009;Hao et al., 2010;Vink et al., 2011;Spaulding et al., 2011). Overall, it appears that 
drug-eluting stents are as safe as bare metal stents, and reduce rates of target vessel 
revascularization. Nonetheless, the choice of drug-eluting stents mandates longer term dual 
antiplatelet therapy than bare metal stents, which is problematic in the patient who may 
require additional surgical revascularization. While the likelihood of finding significant left 
main or multivessel disease in STEMI patients is low (Applegate et al., 2008; Lachance et al., 
2008), there remains strong concerns that incomplete visualization of the coronary anatomy 
prior to PCI in STEMI leads to less than optimal decision-making. Traditional complete 
coronary angiography with multiple orthogonal views followed by left ventriculography is 
ideal but is time consuming in a situation that demands rapid decisions and treatments. 
Many operators have adopted a hybrid approach, which allows evaluation of the left main 
coronary artery with one or two angiograms, and completing a left ventriculogram after the 
PCI. 
We also advocate a hybrid approach as follows (Figure 1) :  if the suspected infarct is located 
in the anterior or lateral left ventricular wall, the first catheter we choose is a left coronary 
artery guide with the purpose of proceeding with immediate revascularization using a bare 
metal or drug-eluting stent. The choice of stent in this situation is dependent on both clinical 
and procedural factors. Our default stent type is a drug-eluting stent unless we are 
uncertain about compliance with dual-antiplatelet therapy, or we believe that left main or 
surgical disease is present and will require CABG. In this setting, we believe that an 
angiogram of the right coronary artery before PCI will not change management. If the 
suspected infarct-related vessel is the right coronary artery, we perform one or two 
diagnostic cine angiograms of the left coronary artery to exclude significant left main 
disease and then perform PCI of the right coronary artery lesion. This identifies left main or 
three-vessel disease prior to PCI and prevents us from placing drug-eluting stents in 
patients that will likely need CABG surgery. For STEMI patients with hemodynamic 
instability, in order to exclude mechanical complications, we also advocate cardiac 
auscultation, quick look echocardiography and/or left ventriculography before stent 
implantation. 
7. Case presentations 
Two cases will be presented to highlight the culprit PCI approach. The first case was a 48-
year-old man, with no previous cardiac history,  who was admitted with an acute antero-
lateral myocardial infarction. The patient was eating dinner at a restaurant when he 
developed progressive chest pain radiating to the jaw and left arm. He also became 
diaphoretic. He presented to an outside emergency department and was then transferred to 
our facility. On physical examination, his vital signs were stable and he had no heart   
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Fig. 1. Algorithm of Hybrid Approach to Primary PCI for STEMI 
BMS = bare metal stent, DES = drug-eluting stent, LV gram =  left ventriculogram, 
echo = echocardiogram 
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murmur. There were no signs of heart failure. His electrocardiogram demonstrated sinus 
rhythm with a normal axis and normal intervals. ST elevations and pathological Q waves 
were present in the anterolateral leads (Figure 2). Laboratory data was not yet available 
on presentation. Coronary angiography was performed first with a 6 French EBU 3.5 
guide catheter (Medtronic Inc., Minneapolis, Minnesota) via the right femoral artery. 
Complete occlusion of the proximal left anterior descending artery was demonstrated 
without evidence of collaterals (Figure 3). Percutaneous coronary intervention was then 
performed with a 2.5 x 12 mm Voyager RX balloon (Abbott Vascular, Chicago, Illinois), 
followed by a Fetch aspiration thrombectomy catheter (MEDRAD Inc., Warrendale, 
Pennsylvania). A 3.0 x 18 mm Xience V RX (Abbott Vascular, Chicago, Illinois), drug-
eluting stent was then implanted successfully. A 3.5 x 16 mm Voyager NC RX balloon 
(Abbott Vascular, Chicago, Illinois) was then used to post-dilate the stent. Coronary 
angiography was then completed. Non-obstructive coronary disease was seen in the right 
coronary artery. The left ventriculogram demonstrated severe anterolateral hypokinesis 
and apical dyskinesis. The ejection fraction was 40%. The patient was discharged three 
days later, free of symptoms. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Case 1, Electrocardiogram 
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Fig. 3. Case 1, Left Coronary Angiogram 
The second case was a 57 year old man with an unknown past medical history who 
presented with chest pain via the emergency medical services to the emergency room. He 
was diagnosed with an STEMI in the ambulance. In the emergency room, he developed 
ventricular fibrillation, requiring cardio-pulmonary resuscitation, multiple cadio - 
defibrillations, and maximum doses of amiodarone and lidocaine. He was intubated. He 
eventually developed a stable ventricular tachycardia and was taken to the cardiac 
catheterization lab. Heart sounds were difficult to appreciate because of the ventilator. His 
initial EKG in the emergency room demonstrated sinus tachycardia at 123 beats per minute, 
a left anterior fascicular block, and ST elevations with pathological Q waves in the inferior 
leads (Figure 4). In the cardiac catheterization lab, the patient required intermittent 
cardiopulmonary resuscitation, while a 6 French 3.5 ART guide catheter (Boston 
Scientific/Scimed, Natick, MA) was used to engage the right coronary artery. The right 
coronary angiogram was the first image acquired. 100% occlusion of the proximal right 
coronary artery was demonstrated and a 2.5 x 12 mm Voyager RX balloon was used to dilate 
the coronary artery (Figure 5). After five low-pressure inflations, a VeriFLEX monorail 2.75 x 
28 mm bare metal stent (BMS) (Boston Scientific/Scimed, Natick, MA) was implanted 
successfully across the lesion. The right coronary artery was, at least, co-dominant. 
Angiography on the left coronary artery was then performed with a diagnostic catheter. 
This demonstrated a stenosis of 50% in the left main coronary artery and a stenosis of 75% in 
the left anterior descending artery (Figure 6). The left ventriculogram demonstrated akinesis 
of the inferior wall and severe hypokinesis of the anterolateral wall. The ejection fraction 
was 35%. An intra-aortic balloon pump was then placed. The patient did very well, post-
procedure. He was extubated two days after admission and was discharged four days after 
admission. The patient did not undergo CABG surgery during that hospitalization, because 
he demanded to leave the hospital. Three months after his initial admission the patient 
underwent CABG. Clopidogrel was discontinued four days prior to the surgery. He 
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Fig. 4. Case 2, Electrocardiogram 
 
 
 
 
 
Fig. 5. Case 2, Right Coronary Angiogram 
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Fig. 6. Case 2, Left Coronary Angiogram 
underwent a three vessel bypass with a free skeletonized right internal mammary artery to  
the first obtuse marginal as a Y graft from the left internal mammary artery, a saphenous 
vein graft to the posterior descending artery from the aorta, and a skeletonized left internal 
mammary artery to the left anterior descending as an arterial graft. The patient had no 
perioperative or postoperative complications. 
8. Conclusion 
Prior to primary PCI, comprehensive coronary angiography, including left ventricular 
imaging can provide valuable information for the care of a patient with a STEMI. This 
approach is time consuming, however, and increased time to reperfusion has been 
associated with worse outcomes. In the two studies presented, a culprit vessel PCI approach 
may decrease door-to- balloon times without compromising patient safety. Randomized 
studies are needed, however, to determine if the incremental decrease in door-to-balloon 
times using this approach provides clinical benefit. We recommend a hybrid approach, 
combining certain aspects of comprehensive coronary angiography and the culprit vessel 
PCI approach. Compared to the femoral approach, the radial arteriotomy is an attractive 
alternative for vascular access even in the setting of primary PCI for STEMI. Operators 
experienced with the radial approach report lower or similar access to reperfusion times 
with the transradial approach compared to the femoral approach. 
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